Sanofi and Bausch Health Companies Inc.: A Detailed Gross Profit Analysis

Sanofi's Gross Profit Soars, Bausch Health Struggles

__timestampBausch Health Companies Inc.Sanofi
Wednesday, January 1, 2014600890000021769000000
Thursday, January 1, 2015785380000023942000000
Friday, January 1, 2016706300000023995000000
Sunday, January 1, 2017617600000024774000000
Monday, January 1, 2018602900000024356000000
Tuesday, January 1, 2019625100000025655000000
Wednesday, January 1, 2020577800000025212000000
Friday, January 1, 2021604000000026920000000
Saturday, January 1, 2022576000000031697000000
Sunday, January 1, 2023619800000031797000000
Loading chart...

Unleashing insights

A Comparative Analysis of Gross Profit: Sanofi vs. Bausch Health

In the ever-evolving pharmaceutical industry, understanding financial performance is crucial. This analysis delves into the gross profit trends of two major players: Sanofi and Bausch Health Companies Inc., from 2014 to 2023. Over this period, Sanofi consistently outperformed Bausch Health, with an average gross profit nearly four times higher. Sanofi's gross profit peaked in 2023, reaching approximately $31.8 billion, marking a 46% increase from 2014. In contrast, Bausch Health's highest gross profit was in 2015, with a notable decline in subsequent years, reflecting industry challenges and strategic shifts. The data highlights Sanofi's robust growth trajectory, while Bausch Health's fluctuating performance underscores the competitive pressures in the pharmaceutical sector. This analysis provides valuable insights for investors and industry analysts seeking to understand the financial dynamics of these healthcare giants.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025